• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艾伯塔省头颈癌幸存者的流行病学趋势:旨在更好地了解疾病负担

Epidemiological trends of head and neck Cancer survivors in Alberta: towards improved understanding of the burden of disease.

作者信息

Song Jin Soo, Vallance Patrick, Biron Vincent, Jeffery Caroline C

机构信息

Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.

Division of Otolaryngology - Head & Neck Surgery, Department of Surgery, University of Alberta, 1E4 Walter Mackenzie Centre, 8440-112 Street NW, Edmonton, Alberta, T6G 2B7, Canada.

出版信息

J Otolaryngol Head Neck Surg. 2020 Jul 6;49(1):46. doi: 10.1186/s40463-020-00443-4.

DOI:10.1186/s40463-020-00443-4
PMID:32631452
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7339434/
Abstract

BACKGROUND

With an increase in the incidence of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) and more favourable survival outcomes, there is now a population of head and neck cancer survivors that are different from preceding decades. In addition, their long-term survivorship issues have become increasing research interests. This study was undertaken to determine the changing epidemiological trends of head and neck cancer survivors in Alberta to better anticipate future demands on healthcare services.

METHODS

The Alberta Cancer Registry was queried for adult (aged > 18 years), head and neck cancer (HNC) patients who were at least 1-year post-treatment completion between 1997 to 2016. Cutaneous head and neck and thyroid cancer patients were excluded. Extracted data was then used to calculate the incidence and prevalence of early (< 5 years from treatment), intermediate (5 to < 10 years from treatment), and late (> 10 years from treatment) survivors of head and neck cancer. Point prevalence of HNC survivors in 2005, 2010, and 2015 were then further stratified by gender, sub-site and age.

RESULTS

Over this time period, head and neck cancer survivors tended to be younger (64.0 vs. 62.1, p = 0.046) and male (M:F 2.45:1 vs 2.54:1). In 1997, the predominant subsites were the oral cavity and larynx at 45.8% and 30.9%, respectively. In 2015 the predominant subsites were the oral cavity and oropharynx at 33.0% and 29.4%, respectively. Within the cohort, the prevalence of late HNC survivors increased to 13.3 per 100,000 people in 2015.

CONCLUSIONS

There is a significant population of head and neck survivors who are younger, male, and more than 10 years post-treatment. While oral cavity cancers have shown stable disease prevalence in recent decades, the number of OPSCC survivors have increased. With an improved understanding of the distribution and characteristics of HNC survivors, a more guided healthcare support network can be fostered for these patients.

摘要

背景

随着人乳头瘤病毒(HPV)相关的口咽鳞状细胞癌(OPSCC)发病率的上升以及生存结果更为乐观,现在有一群头颈癌幸存者与过去几十年有所不同。此外,他们的长期生存问题越来越受到研究关注。本研究旨在确定艾伯塔省头颈癌幸存者不断变化的流行病学趋势,以便更好地预测未来对医疗服务的需求。

方法

查询艾伯塔癌症登记处,获取1997年至2016年间完成治疗至少1年的成年(年龄>18岁)头颈癌(HNC)患者。皮肤头颈癌和甲状腺癌患者被排除。然后使用提取的数据计算头颈癌早期(治疗后<5年)、中期(治疗后5至<10年)和晚期(治疗后>10年)幸存者的发病率和患病率。然后按性别、亚部位和年龄进一步分层,分析2005年、2010年和2015年头颈癌幸存者的点患病率。

结果

在此期间,头颈癌幸存者往往更年轻(64.0岁对62.1岁,p = 0.046)且男性居多(男:女为2.45:1对2.54:1)。1997年,主要亚部位分别是口腔和喉部,占比分别为45.8%和30.9%。2015年,主要亚部位分别是口腔和口咽,占比分别为33.0%和29.4%。在该队列中,2015年末期头颈癌幸存者的患病率增至每10万人中有13.3人。

结论

有相当数量的头颈癌幸存者更年轻、为男性且治疗后超过10年。虽然近几十年来口腔癌的疾病患病率保持稳定,但口咽鳞状细胞癌幸存者的数量有所增加。随着对头颈癌幸存者分布和特征的进一步了解,可以为这些患者建立更有针对性的医疗支持网络。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7517/7339434/141a3e68c237/40463_2020_443_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7517/7339434/bbe5b2c2aef2/40463_2020_443_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7517/7339434/b47328b4a1aa/40463_2020_443_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7517/7339434/141a3e68c237/40463_2020_443_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7517/7339434/bbe5b2c2aef2/40463_2020_443_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7517/7339434/b47328b4a1aa/40463_2020_443_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7517/7339434/141a3e68c237/40463_2020_443_Fig3_HTML.jpg

相似文献

1
Epidemiological trends of head and neck Cancer survivors in Alberta: towards improved understanding of the burden of disease.艾伯塔省头颈癌幸存者的流行病学趋势:旨在更好地了解疾病负担
J Otolaryngol Head Neck Surg. 2020 Jul 6;49(1):46. doi: 10.1186/s40463-020-00443-4.
2
Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.美国 HPV 相关和 HPV 不相关头颈部癌症幸存者的合并症患病率及其对生存的影响。
Cancer. 2019 Jan 15;125(2):249-260. doi: 10.1002/cncr.31800. Epub 2018 Nov 16.
3
Suicide risk among cancer survivors: Head and neck versus other cancers.癌症幸存者的自杀风险:头颈部癌症与其他癌症。
Cancer. 2018 Oct 15;124(20):4072-4079. doi: 10.1002/cncr.31675. Epub 2018 Oct 18.
4
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
5
Understanding financial toxicity in head and neck cancer survivors.了解头颈部癌症幸存者的财务毒性。
Oral Oncol. 2019 Aug;95:187-193. doi: 10.1016/j.oraloncology.2019.06.023. Epub 2019 Jun 28.
6
Adverse respiratory outcomes among head and neck cancer survivors in the Utah Cancer Survivors Study.犹他癌症幸存者研究中的头颈部癌症幸存者的不良呼吸结局。
Cancer. 2020 Feb 15;126(4):879-885. doi: 10.1002/cncr.32617. Epub 2019 Nov 13.
7
Burden of treatment: Reported outcomes in a head and neck cancer survivorship clinic.治疗负担:头颈部癌症生存者诊所的报告结果。
Laryngoscope. 2019 Dec;129(12):E437-E444. doi: 10.1002/lary.27801. Epub 2019 Jan 15.
8
International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site.头颈癌发病率的国际趋势:按国家、性别和解剖部位的差异
Oral Oncol. 2014 May;50(5):387-403. doi: 10.1016/j.oraloncology.2014.01.016. Epub 2014 Feb 13.
9
Tracking changes in age distribution of head and neck cancer in the United States from 1975 to2016.追踪 1975 年至 2016 年美国头颈部癌症年龄分布变化。
Clin Otolaryngol. 2021 Nov;46(6):1205-1212. doi: 10.1111/coa.13817. Epub 2021 Jun 24.
10
Prevalence of Fatigue in Head and Neck Cancer Survivors.头颈癌幸存者疲劳的患病率。
Ann Otol Rhinol Laryngol. 2019 May;128(5):413-419. doi: 10.1177/0003489419826138. Epub 2019 Jan 30.

引用本文的文献

1
Blood and saliva-derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus-associated head and neck cancer.血液和唾液来源的 ctDNA 是治疗后残留疾病的标志物,与 HPV 相关的头颈部癌症的复发相关。
Cancer Med. 2023 Aug;12(15):15777-15787. doi: 10.1002/cam4.6191. Epub 2023 Aug 1.
2
The current status of nanotechnological approaches to therapy and drug delivery in otolaryngology: A contemporary review.纳米技术在耳鼻咽喉科治疗和药物递送中的应用现状:当代综述
Laryngoscope Investig Otolaryngol. 2022 Oct 20;7(6):1762-1772. doi: 10.1002/lio2.952. eCollection 2022 Dec.
3

本文引用的文献

1
Cancer treatment and survivorship statistics, 2019.2019 年癌症治疗与生存统计
CA Cancer J Clin. 2019 Sep;69(5):363-385. doi: 10.3322/caac.21565. Epub 2019 Jun 11.
2
Treatment trends in head and neck cancer: Surveillance, Epidemiology, and End Results (SEER) Patterns of Care analysis.头颈部癌症的治疗趋势:监测、流行病学和最终结果(SEER)的治疗模式分析。
Cancer Causes Control. 2019 Jul;30(7):721-732. doi: 10.1007/s10552-019-01185-z. Epub 2019 May 22.
3
Long-term survival and swallowing outcomes in advanced stage oropharyngeal squamous cell carcinomas.
Margin Sampling and Survival Outcomes in Oral Cavity and p16-Positive Oropharyngeal Squamous Cell Carcinoma.
口腔及p16阳性口咽鳞状细胞癌的切缘取样与生存结果
OTO Open. 2022 Sep 21;6(3):2473974X221101024. doi: 10.1177/2473974X221101024. eCollection 2022 Jul-Sep.
4
The effect of local anaesthetic biopsy in head and neck cancer on cancer pathway waiting times.头颈部癌症局部麻醉活检对癌症通路等待时间的影响。
Ann R Coll Surg Engl. 2023 Apr;105(4):331-335. doi: 10.1308/rcsann.2022.0014. Epub 2022 May 26.
5
Construction of an m6A-related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma.构建 m6A 相关 lncRNA 对预后标志物并预测头颈部鳞状细胞癌的免疫图谱。
J Clin Lab Anal. 2022 Jan;36(1):e24113. doi: 10.1002/jcla.24113. Epub 2021 Nov 16.
6
The expression profile and clinical application value of hsa_circ_0016148 in head and neck squamous cell carcinoma.hsa_circ_0016148 在头颈部鳞状细胞癌中的表达谱及临床应用价值。
J Clin Lab Anal. 2021 Nov;35(11):e23997. doi: 10.1002/jcla.23997. Epub 2021 Sep 30.
7
Clinicopathological Features of Patients Nominated for Head and Neck Biopsies: A One-Year Series.接受头颈部活检患者的临床病理特征:一项为期一年的研究系列
Cureus. 2021 Mar 3;13(3):e13666. doi: 10.7759/cureus.13666.
晚期口咽鳞状细胞癌的长期生存及吞咽结局
Papillomavirus Res. 2019 Jun;7:1-10. doi: 10.1016/j.pvr.2018.09.002. Epub 2018 Sep 26.
4
Epidemiology and Demographics of the Head and Neck Cancer Population.头颈部癌人群的流行病学与人口统计学
Oral Maxillofac Surg Clin North Am. 2018 Nov;30(4):381-395. doi: 10.1016/j.coms.2018.06.001. Epub 2018 Aug 3.
5
Long-term quality of life and psycho-social outcomes after oropharyngeal cancer surgery and radial forearm free-flap reconstruction: A GETTEC prospective multicentric study.口咽癌手术及游离桡侧前臂皮瓣重建术后的长期生活质量及心理社会结局:一项GETTEC前瞻性多中心研究。
Surg Oncol. 2018 Mar;27(1):23-30. doi: 10.1016/j.suronc.2017.11.005. Epub 2017 Nov 24.
6
Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study.美国头颈癌的流行病学趋势:一项监测、流行病学和最终结果(SEER)人群研究
J Oral Maxillofac Surg. 2017 Dec;75(12):2562-2572. doi: 10.1016/j.joms.2017.05.008. Epub 2017 May 22.
7
Eliciting Preferences for Clinical Follow-Up in Patients with Head and Neck Cancer Using Best-Worst Scaling.使用最佳-最差标度法引出头颈癌患者对临床随访的偏好。
Value Health. 2017 Jun;20(6):799-808. doi: 10.1016/j.jval.2017.01.012. Epub 2017 Mar 31.
8
Delayed lower cranial neuropathy after oropharyngeal intensity-modulated radiotherapy: A cohort analysis and literature review.口咽调强放疗后迟发性下颅神经病变:一项队列分析及文献综述
Head Neck. 2017 Aug;39(8):1516-1523. doi: 10.1002/hed.24789. Epub 2017 Apr 28.
9
Cancer incidence attributable to alcohol consumption in Alberta in 2012.2012年艾伯塔省因饮酒导致的癌症发病率。
CMAJ Open. 2016 Sep 21;4(3):E507-E514. doi: 10.9778/cmajo.20160070. eCollection 2016 Jul-Sep.
10
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 32 种癌症组别的伤残调整生命年数,1990 年至 2015 年:全球疾病负担研究的系统分析。
JAMA Oncol. 2017 Apr 1;3(4):524-548. doi: 10.1001/jamaoncol.2016.5688.